Simulations Plus, Inc. (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, announced the successful completion of its 2026 Spring School, a global training initiative designed to expand access to model-informed drug development (MIDD) and strengthen the scientific foundation of the industry’s future workforce.
More than 1,400 scientists from industry, academia, and regulatory agencies from over 65 countries participated in the week-long program, reflecting the high demand for expert-led training as modeling and simulation increasingly become standard for drug development strategy, regulatory engagement, and clinical execution.
“As model-informed approaches become central to how therapies are developed, it is vital to apply modeling and simulation consistently across teams,” said Jonathan Chauvin, Co-Chief Product and Technology Officer of Simulations Plus. “Through programs like Spring School, we are expanding access to these capabilities to support the next generation of scientists, while enabling broader adoption of model-informed workflows across the industry. These foundational skills are essential for scientists to evolve with the discipline and leverage validated scientific engines and AI-enabled ecosystems to support better decision-making across the drug development lifecycle.”
Held from March 23 to 27, 2026, the Spring School program offered two tracks: GastroPlus® Spring School: From PBPK Basics to Biopharmaceutics Applications , and MonolixSuite™ Spring School: High-Impact Pharmacometrics Case Studies . Both tracks included interactive lectures, hands-on exercises, and live Q&A sessions led by Simulations Plus experts.
“The continued scale and diversity of participation in this year’s program reflects how quickly model-informed approaches are becoming embedded across the global scientific community,” said Jennifer Johnson, Manager of Learning Services of Simulations Plus. “Our focus is on building programs that not only educate but also help scientists translate these methods into real-world workflows and collaborative environments.”
Simulations Plus has a long-standing commitment to education. In addition to its Spring School, the Company has previously offered Summer and Autumn Schools focused on PK/PD modeling. The most recent Autumn School was the first program to offer a second track focused on PBPK modeling. In addition to these programs, Simulations Plus is widely known for its University+ program, which provides free academic access to modeling and simulation software for thousands of students and educators worldwide. Together, these initiatives form a cornerstone of the Company’s global educational outreach—helping expand the adoption of model-informed approaches and strengthening the pipeline of scientists equipped to apply these methods across the drug development lifecycle.
